Documents Eugm 2011 mehta - adaptive designs for phase 3 oncology trials

1. Adaptive Designs for Phase 3 Oncology Trials: Case Study and Extensions Cytel User Group Meeting, Paris October 13, 2011 Cyrus Mehta, Ph.D. President, Cytel Inc., Cambridge,…